Expand KNSA Menu
KNSA MENU

Kiniksa Pharmaceuticals International PLC - Class A (KNSA) closed at $95.05 on November 18, 2026, down 0.1% from the previous close, on volume of 315,825 shares (30-day average 782,454).

Key numbers
  • Last close: $95.05 (November 18, 2026)
  • 52-week range: $37.02 to $99.31
  • Market value: $7.5 billion
  • 30-day implied volatility (IV30): 53.8%
  • Option volume: 1,639 contracts (1,614 calls, 25 puts); 30-day average 1,935

Data as of November 18, 2026.

KNSA Stock Summary and Trading Ideas (Kiniksa Pharmaceuticals International PLC - Class A | NASDAQ:KNSA)

Charts for Today's Stock Price and Implied Volatility in Kiniksa Pharmaceuticals International PLC - Class A

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for KNSA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Kiniksa Pharmaceuticals International PLC - Class A (KNSA) Frequently Asked Questions

What does Kiniksa Pharmaceuticals International PLC - Class A do?

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

What symbol and exchange does Kiniksa Pharmaceuticals International PLC - Class A shares trade?

Kiniksa Pharmaceuticals International PLC - Class A trades on the NASDAQ stock market under the symbol KNSA.

What is Kiniksa Pharmaceuticals International PLC - Class A stock price doing today?

As of November 19, 2026, KNSA stock price climbed to $95.21 with 163,378 million shares trading.

What is Kiniksa Pharmaceuticals International PLC - Class A's Beta?

KNSA has a beta of 0.07, meaning it tends to be less sensitive to market movements. KNSA has a correlation of 0.00 to the broad based SPY ETF.

How much is Kiniksa Pharmaceuticals International PLC - Class A worth?

KNSA has a market cap of $7.48 billion. This is considered a Mid Cap stock.

How much money does Kiniksa Pharmaceuticals International PLC - Class A make?

Last quarter Kiniksa Pharmaceuticals International PLC - Class A reported $286 million in Revenue and $.56 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.23.

What is the highest and lowest price Kiniksa Pharmaceuticals International PLC - Class A traded in the last 3 year period?

In the last 3 years, KNSA traded as high as $99.31 and as low as $15.51.

What are the top ETFs holding Kiniksa Pharmaceuticals International PLC - Class A?

The top ETF exchange traded funds that KNSA belongs to (by Net Assets): IWM, VTI, VB, VBK, IWO.

Is Kiniksa Pharmaceuticals International PLC - Class A (KNSA) a good investment?

KNSA has outperformed the market in the last year with a price return of +130.6% while the SPY ETF gained +10.9%. KNSA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.8% and -0.9%, respectively, while the SPY returned -5.4% and -5.5%, respectively.

What are the support and resistance levels for Kiniksa Pharmaceuticals International PLC - Class A (KNSA)?

KNSA support price is $91.94 and resistance is $98.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KNSA shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes